Evidence map›Paper›PMID 34776211›Full record

ArticleMethods in enzymology2021

Genomic mapping of DNA-repair reaction intermediates in living cells with engineered DNA structure-trap proteins.

Jingjing Liu, Qian Mei, Sadeieh Nimer, Devon M Fitzgerald, Susan M Rosenberg

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jingjing LiuDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Qian MeiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, United States; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States; Systems, Synthetic, and Physical Biology Program, Rice University, Houston, TX, United States.
Sadeieh NimerDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, United States; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
Devon M FitzgeraldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, United States; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
Susan M RosenbergDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, United States; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States; Systems, Synthetic, and Physical Biology Program, Rice University, Houston, TX, United States. Electronic address: smr@bcm.edu.
Baylor College of Medicine · US

Funding

Harnessing Proteins as Drugs: the Protectome of Cancer- and Aging-Prevention ProteinsDP1AG072751 · NIA · BAYLOR COLLEGE OF MEDICINE · PI ROSENBERG, SUSAN M · 2020 to 2024
$5.6M
Mechanisms of Endogenous DNA Damage PromotionR01CA250905 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MILLER, KYLE M, ROSENBERG, SUSAN M · 2020 to 2024
$3.3M
MOLECULAR MECHANISMS OF STRESS-INDUCED MUTATIONR35GM122598 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROSENBERG, SUSAN M · 2017 to 2020
$2.4M
NCI NIH HHS R01 CA250905NIA NIH HHS DP1 AG072751NIGMS NIH HHS R35 GM122598
6 · The paper itself

Abstract

Diverse DNA structures occur as reaction intermediates in various DNA-damage and -repair mechanisms, most of which results from replication stress. We harness the power of proteins evolutionarily optimized to bind and "trap" specific DNA reaction-intermediate structures, to quantify the structures, and discern the mechanisms of their occurrence in cells. The engineered proteins also allow genomic mapping of sites at which specific DNA structures occur preferentially, using a structure-trapping protein and ChIP-seq- or Cut-and-Tag-like methods. Genome-wide identification of sites with recurrent DNA-damage intermediates has illuminated mechanisms implicated in genome instability, replication stress, and chromosome fragility. Here, we describe X-seq, for identifying sites of recurrent four-way DNA junctions or Holliday-junctions (HJs). X-seq uses an engineered, catalysis-defective mutant of Escherichia coli RuvC HJ-specific endonuclease, RuvCDefGFP. X-seq signal indicates sites of recombinational DNA repair or replication-fork stalling and reversal. We also describe methods for genomic mapping of 3'-single-stranded DNA ends with SsEND-seq, in E. coli. Both methods allow genomic profiling of DNA-damage and -repair intermediates, which can precede genome instability, and are expected to have many additional applications including in other cells and organisms.

Indexed as

Escherichia coliEscherichia coli ProteinsDNADNA, CruciformDNA RepairDNA ReplicationGenomicsDNADNA, CruciformEscherichia coli Proteins3'-ending single-stranded DNADNA damageDNA repairDNA replication stressHolliday junctionsReplication-fork reversal

Identifiers

PMID34776211
PMCPMC9502303
OpenAlexW3211945028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.